BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36264169)

  • 1. Predictive Value of the
    Yu X; Mao SQ; Shan YY; Huang Y; Wu SD; Lu CD
    Genet Test Mol Biomarkers; 2022 Oct; 26(10):476-484. PubMed ID: 36264169
    [No Abstract]   [Full Text] [Related]  

  • 2. TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma.
    Li Y; Wu J; Li E; Xiao Z; Lei J; Zhou F; Yin X; Hu D; Mao Y; Wu L; Wenjun L
    Cancer Biol Ther; 2022 Dec; 23(1):439-445. PubMed ID: 35921289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-fetoprotein and
    Yang Z; Luo FZ; Wang S; Lerut J; Zhuang L; Li QY; Xu X; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):229-234. PubMed ID: 32303439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of serum α-fetoprotein level on short-term recurrence after R0 resection in primary hepatocellular carcinoma].
    Li SP; Wu LQ
    Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):600-3. PubMed ID: 24256584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation.
    Nörthen A; Asendorf T; Walson PD; Oellerich M
    Clin Biochem; 2018 Feb; 52():20-25. PubMed ID: 29054441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma.
    Xue M; Wu Y; Fan W; Guo J; Wei J; Wang H; Tan J; Wang Y; Yao W; Zhao Y; Li J
    Cancer Res Treat; 2020 Jul; 52(3):925-937. PubMed ID: 32229792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma.
    Halazun KJ; Rosenblatt RE; Mehta N; Lai Q; Hajifathalian K; Gorgen A; Brar G; Sasaki K; Doyle MBM; Tabrizian P; Agopian VG; Najjar M; Ivanics T; Samstein B; Brown RS; Emond JC; Yao F; Lerut J; Rossi M; Mennini G; Iesari S; Finkenstedt A; Schaefer B; Mittler J; Hoppe-Lotichius M; Quintini C; Aucejo F; Chapman W; Sapisochin G
    JAMA Surg; 2021 Jun; 156(6):559-567. PubMed ID: 33950167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 rs28934571 polymorphism increases the prognostic risk in hepatocellular carcinoma.
    Zhao Y; Zhu C; Chang Q; Yang J; Liu Y; Peng P; Liu C; Cheng R; Chen X; Wu Y; Cheng L; Hu L; Wu X; Yin J
    Biomark Med; 2021 Jun; 15(9):615-622. PubMed ID: 34037458
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.
    Jin J; Zhu P; Liao Y; Li J; Liao W; He S
    Oncotarget; 2015 Aug; 6(22):19217-27. PubMed ID: 26057470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
    Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
    Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a prognostic model for predicting short-term disease-free survival in cases of hepatitis B-related hepatocellular carcinoma with the TP53 249Ser mutation in southern China.
    Qin W; Han C; Mai R; Yu T; Shang L; Ye X; Zhu G; Su H; Liao X; Liu Z; Yu L; Liu X; Yang C; Wang X; Peng M; Peng T
    Transl Cancer Res; 2020 Aug; 9(8):4517-4533. PubMed ID: 35117817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Long-To-Short-Axis Ratio and Multifocality are Associated With TP53 Mutation Status in Surgically Resected Hepatocellular Carcinomas.
    Wang X; Chen D; Chen B
    Acad Radiol; 2020 Dec; 27(12):1720-1726. PubMed ID: 29941397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.
    Duvoux C; Roudot-Thoraval F; Decaens T; Pessione F; Badran H; Piardi T; Francoz C; Compagnon P; Vanlemmens C; Dumortier J; Dharancy S; Gugenheim J; Bernard PH; Adam R; Radenne S; Muscari F; Conti F; Hardwigsen J; Pageaux GP; Chazouillères O; Salame E; Hilleret MN; Lebray P; Abergel A; Debette-Gratien M; Kluger MD; Mallat A; Azoulay D; Cherqui D;
    Gastroenterology; 2012 Oct; 143(4):986-94.e3; quiz e14-5. PubMed ID: 22750200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.
    Giard JM; Mehta N; Dodge JL; Roberts JP; Yao FY
    Transplantation; 2018 May; 102(5):816-822. PubMed ID: 29505494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
    Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
    Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?
    Hsieh CB; Chen TW; Chu CM; Chu HC; Yu CP; Chung KP
    World J Gastroenterol; 2010 Jun; 16(24):3049-55. PubMed ID: 20572309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.